Triple-action weekly weight loss drug cut sleep apnea in two late-stage trials
Medical Xpress reports a once-weekly triple agonist reduced sleep apnea across two late-stage studies. Tap through for the trial results.
Recap by typeshit. Full story at Medical Xpress.